GEF-H1 inhibitors are chemical compounds designed to interfere with the activity of GEF-H1, a guanine nucleotide exchange factor (GEF) that plays a crucial role in the regulation of Rho GTPases. Rho GTPases are signaling molecules involved in various cellular processes such as cytoskeleton organization, cell migration, proliferation, and gene expression. GEF-H1 is known to activate RhoA by facilitating the exchange of GDP for GTP, which promotes actin cytoskeletal dynamics and cellular contractility. By inhibiting GEF-H1, these compounds modulate the downstream signaling of Rho GTPases, affecting pathways involved in cellular morphology, motility, and other functions governed by cytoskeletal changes. Structurally, GEF-H1 inhibitors can vary, but they generally have the capacity to bind to GEF-H1's active site or its regulatory regions, blocking its interaction with RhoA or other GTPases. This inhibition can disrupt the normal cycling between active (GTP-bound) and inactive (GDP-bound) states of Rho GTPases, ultimately altering cellular behavior.
The design of GEF-H1 inhibitors often involves targeting key regions within the protein that are critical for its GEF activity. Such inhibitors may exhibit specificity for GEF-H1 over other GEFs, owing to the unique structural features of GEF-H1, including its DH-PH domain tandem, which is central to its guanine nucleotide exchange activity. Due to the essential role of GEF-H1 in controlling cellular cytoskeletal dynamics and the associated signaling pathways, inhibitors of GEF-H1 are valuable tools for probing the molecular mechanisms of Rho GTPase regulation. They provide insights into the biological processes controlled by GEF-H1, such as cellular shape changes, migration, and signal transduction, as well as the cross-talk between microtubules and actin filaments within cells. The specificity and potency of these inhibitors allow researchers to dissect the contributions of GEF-H1 to complex cellular processes, providing a clearer understanding of its role in cellular physiology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can alter chromatin structure and potentially downregulate GEF-H1 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that can lead to DNA demethylation and possibly upregulate or downregulate GEF-H1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a MEK inhibitor which might decrease ERK pathway signaling, potentially leading to reduced GEF-H1 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that could indirectly lead to altered transcription factor activity affecting GEF-H1 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a PI3K inhibitor which may result in downstream inhibition of Akt signaling, potentially reducing GEF-H1 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which could lead to decreased protein synthesis, including the synthesis of GEF-H1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor and may downregulate inflammatory response pathways, potentially influencing GEF-H1 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate transcription factors and inflammatory pathways, which could lead to a decrease in GEF-H1 expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences sirtuin activity and may impact signaling pathways that regulate GEF-H1 expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane is known to affect the Nrf2 pathway which could lead to changes in the expression of various genes including GEF-H1. | ||||||